🏅 FDA Orphan Designation
Exkivity
mobocertinib
Manufacturer: Takeda Development Center Americas, Inc.
Indicated for:📚 Malignant germ cell tumor of the cervix uteri
Indications & Usage
Treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy (Indication withdrawn)
💙 Support Programs
View all →Exkivity
Takeda Development Center Americas, Inc.
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.